EOC317
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC50s of 6, 2 and 4 nM for FGFR1, VEGFR2 and Tie-2.
Product Specifications
CAS Number
[939805-30-8]
Product Name Alternative
ACTB-1003
UNSPSC
12352005
Target
FGFR; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ACTB-1003.html
Purity
98.01
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC(C(F)(F)F)=CC=C1F)NC2=CC=C(C3=C4C(N)=NC=NN4C(CN5CCOCC5)=C3COC)C=C2F
Molecular Formula
C27H26F5N7O3
Molecular Weight
591.53
References & Citations
[1]Patel K, et al. ACTB-1003: An oral kinase inhibitor targeting cancer mutations (FGFR), angiogenesis (VEGFR2, TEK), and induction of apoptosis (RSK and p70S6K) . Journal of Clinical Oncology 28, no. 15 DOI: 10.1200/jco.2010.28.15_suppl.e13665
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
VEGFR2/KDR/Flk-1
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx301992-01 20 µg
GRAM Domain Containing Protein 1B (GRAMD1B) Antibody
Sign In for Pricing
View Details abx301992-02 50 µg
GRAM Domain Containing Protein 1B (GRAMD1B) Antibody
Sign In for Pricing
View Details 
abx301992-03 100 µg
GRAM Domain Containing Protein 1B (GRAMD1B) Antibody
Sign In for Pricing
View Details